Literature DB >> 12543281

Clinical effectiveness of laparoscopic fundoplication in a U.S. community.

Nimish Vakil1, Michael Shaw, Russell Kirby.   

Abstract

BACKGROUND: The aim of our study was to determine the outcome of laparoscopic fundoplication for reflux disease in a cohort of patients who underwent this procedure in routine clinical practice.
METHODS: We identified 151 patients who had undergone laparoscopic fundoplication in a managed care organization in Milwaukee. Symptoms were evaluated using a validated questionnaire. Postoperative medication use and endoscopic and surgical procedures were recorded.
RESULTS: Eighty-seven patients agreed to participate, of whom 80 (41 [51%] men) were eligible. Their mean (+/- SD) age was 45 +/- 12 years, and the mean duration after surgery was 20 +/- 10 months. Thirty-six patients (45%) underwent the procedure because their physician recommended it, and 22 (27%) because they thought it would cure their disease. Forty-three patients (61%) were satisfied with the outcome of the procedure. Twenty-six patients (32%) were taking medications on a regular basis for treatment of heartburn, 9 (11%) required esophageal dilation for dysphagia, and 6 (7%) had repeat surgical procedures. Of the 54 patients (67%) who reported new symptoms after surgery, 38 reported excessive gas, 22 reported abdominal bloating, and 22 reported dysphagia. Health-related quality of life was significantly lower in patients with these symptoms.
CONCLUSION: Medical therapy is required for control of heartburn in approximately one third of patients after laparoscopic fundoplication. New symptoms are common after surgery. Patients need to be better informed about the indications and outcomes of surgery.

Entities:  

Mesh:

Year:  2003        PMID: 12543281     DOI: 10.1016/s0002-9343(02)01390-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  36 in total

Review 1.  Endoscopic antireflux procedures.

Authors:  J Arts; J Tack; J P Galmiche
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 2.  Management of the patient with incomplete response to PPI therapy.

Authors:  Peter J Kahrilas; Guy Boeckxstaens; Andre J P M Smout
Journal:  Best Pract Res Clin Gastroenterol       Date:  2013-06       Impact factor: 3.043

3.  Causes of, and therapeutic approaches for, proton pump inhibitor-resistant gastroesophageal reflux disease in Asia.

Authors:  Yoshikazu Kinoshita; Shunji Ishihara
Journal:  Therap Adv Gastroenterol       Date:  2008-11       Impact factor: 4.409

Review 4.  Outcomes of fundoplication: causes for concern, newer options.

Authors:  E Hassall
Journal:  Arch Dis Child       Date:  2005-10       Impact factor: 3.791

5.  Endoscopic treatment for gastroesophageal reflux disease: should you learn the techniques?

Authors:  Julia J Liu
Journal:  Can J Gastroenterol       Date:  2007-04       Impact factor: 3.522

6.  Use of antireflux medication after antireflux surgery.

Authors:  Bas P L Wijnhoven; Carolyn J Lally; John J Kelly; Jennifer C Myers; David I Watson
Journal:  J Gastrointest Surg       Date:  2007-12-11       Impact factor: 3.452

7.  A one-year follow-up study of endoluminal gastroplication (Endocinch) in GERD patients refractory to proton pump inhibitor therapy.

Authors:  J Arts; T Lerut; P Rutgeerts; D Sifrim; J Janssens; J Tack
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

Review 8.  Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs.

Authors:  J Dent; D Armstrong; B Delaney; P Moayyedi; N J Talley; N Vakil
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  Surgical management of gastroesophageal reflux disease in obesity.

Authors:  Sayeed Ikramuddin
Journal:  Dig Dis Sci       Date:  2008-07-29       Impact factor: 3.199

10.  Symptom-focused results after laparoscopic fundoplication for refractory gastroesophageal reflux disease--a prospective study.

Authors:  Stavros A Antoniou; Panagiotis Delivorias; George A Antoniou; Ioannis Natsiopoulos; Athanasios Kalambakas; Jan Dalenbäck; Charalambos Makridis
Journal:  Langenbecks Arch Surg       Date:  2008-02-20       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.